Liver Cancer
Copyright ©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 14, 2007; 13(2): 228-235
Published online Jan 14, 2007. doi: 10.3748/wjg.v13.i2.228
Table 2 Suppression of ISG induction in HepG2.2.15 cells, effect of lamivudine treatment
GeneAcc. No.HepG22.2.15HepG2/lam2.2.15/lam
I complete inhibition
MxAM338825.90.64.00.8
cig5AF0269412.20.92.11.2
II partial inhibition
IFITM3X573523.41.63.41.8
IFITM2X573512.71.62.21.8
III reversible inhibition
IFI 6-16BC0156037.94.47.26.5
IFITM1M245944.92.54.84.6
IV no inhibition
2-5OASD000683.84.04.45.8
MxBM308181.42.01.41.9
Caspase 7U673192.32.42.22.1
IFI 17J041643.32.92.82.7
IFI 27X673251.92.11.82.2
IFI T4U728822.71.92.61.8
RING4X575222.42.32.53.5